FB23-2 (FB23-2; FB-23-2; FB 232) is a novel, potent and selective inhibitor of mRNA N6-methyladenosine (m6A) demethylase FTO with potential anticancer activity.

MitoBloCK 6 is a novel and potent Erv1/ALR inhibitor.

RRx-001 (RRx001; ABDNAZ) is a novel hypoxia-selective epigenetic modulator with potential radiosensitizing and anticancer activity.

β-Elemonic acid is a novel and potent naturally occurring triterpene, isolated from Boswellia carterii.

ICCB-280 is a novel and potent C/EBPα inducer .

Atractylenolide III is a novel and potent apoptosis inductive agent.

Aromadedrin, isolated from Bauhinia championii (Benth), also known as Dihydrokaempferol, is a novel and potent inhibitor of protein kinase C. Dihydrokaempferol in an inducer of apoptosis and is an inhibitor of Bcl-2 and Bcl-xL expression.

Evofosfamide (TH-302) is potent and selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.

ADT-OH is a analogue of anethole dithiolethione (ADT) and synthetic hydrogen sulfide (H2S) donor.

Y-320 is a novel, potent and orally bioactive, phenylpyrazoleanilide immunomodulator, which inhibits IL-17 production by CD4 T cells stimulated with IL-15 with IC50 of 20 to 60 NM.